Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury’s out on whether the medications caused the eye trouble, according to a new small study. The study reviewed the cases of nine people who developed sight-robbing issues, such as dysfunction in blood vessels around the eye’s optic nerve, after taking a GLP-1.  “We’re trying to elucidate if being on these drugs can increase your risk,” said study co-author Dr. Norah Lincoff. She’s a neuro-ophthalmologist and professor of neurology at the University at Buffalo. The study, published recently in JAMA Opthalmology, focused on nine patients, all in their 50s or 60s, who were taking GLP-1s such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound). Seven of the nine patients developed a condition known as nonarteritic anterior ischemic optic neuropathy (NAION). This occurs when blood vessels fail to supply enough blood to the optic nerve, which is crucial for sight. In NAION, damage to the nerve can lead to a sudden and permanent partial loss of vision. Lead study author Dr. Bradley Katz, of the John A. Moran Eye Center at University of Utah Health in Salt Lake City, first noted the issue in a patient who experienced a sudden and painless loss of vision in one eye after starting seamglutide. The patient briefly halted use of the drug, but when…  read on >  read on >

Many women may opt for a breast reduction if they encounter issues such as recurrent neck, back and shoulder pain.   However, a new study suggests a link between these procedures in teens and young adult women and later weight gain. “These patients should be targeted for healthy lifestyle changes to prevent weight gain,” said study lead author William Doyle Jr., a medical student at the University of South Florida in Tampa. He and his colleagues published their findings in the February issue of Plastic and Reconstructive Surgery. Excess weight can raise risks for complications after breast-reduction surgeries (mammaplasty), especially among teens, according to background information from the researchers. For that reason, overweight patients are advised to lose weight prior to these procedures. But what about weight gain after these surgeries? To learn more, Doyle’s team tracked outcomes for 56 patients under the age of 22 (average age: 18.6 years) who had breast reduction surgeries between 2015 and 2019. Prior to their surgeries, about 29% were determined to be at a healthy weight, while the rest had BMIs in the overweight or obese range. BMI, shorthand for body mass index, is a measure of body fat based on height and weight. The researchers tracked fluctuations in patients’ weight for an average of almost two years post-surgery.  They found that 39.3% of patients had any decrease…  read on >  read on >

“Yo-yo” dieting — repeatedly losing and gaining weight — can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics with greater weight fluctuations experienced a 40% decline in their kidneys’ ability to filter toxins from the blood, researchers reported Feb. 4 in the Journal of Clinical Endocrinology & Metabolism. “We showed that high body-weight variability is associated with increased risk of different outcomes of diabetic kidney disease progressions (DKD) in people with type 1 diabetes, independently of traditional DKD risk factors,” lead researcher Dr. Marion Camoin with the University Hospital Center Bordeaux in France said in a news release. “To our knowledge, this is the first study showing this association,” Camoin added. As many as 35% of men and 55% of women yo-yo diet, and this pattern of weight loss and regain has been shown to increase risk of heart disease in both healthy people and people with diabetes, researchers said in background notes. Type 1 diabetes has long been considered a disease of lean people, but obesity is becoming more common in that group as well as the general public, researchers said. For the study, researchers examined six years of body weight data for more than 1,400 people participating in a long-term diabetes health study. The team compared weight fluctuation with six criteria that show how…  read on >  read on >

Tiny microplastics are making their way into the human brain, and new research suggests the problem is getting worse. The new study, published Feb. 3 in the journal Nature, found that brain samples collected in 2024 contained significantly more microplastics than those taken eight years earlier. Researchers say the amount of plastic in the brain has increased by about 50% — the equivalent of an entire plastic spoon in weight. “Compared to autopsy brain samples from 2016, that’s about 50% higher,” he said. “That would mean that our brains today are 99.5% brain and the rest is plastic,” co-lead author Matthew Campen, a professor of pharmaceutical sciences at the University of New Mexico in Albuquerque, told CNN. Researchers also found that people with dementia had even higher levels of microplasticsplastic fragments in their brains — three to five times more than those without dementia. “It’s a little bit alarming, but remember that dementia is a disease where the blood brain barrier and clearance mechanisms are impaired,” Campen said. Microplastics — tiny fragments of plastic that come from products like water bottles, food packaging and synthetic fabrics — have been found in major organs, including the lungs, heart, liver and even the placenta. But scientists are still trying to understand how they affect the body. “The biggest question is, ‘OK, what are these particles doing to…  read on >  read on >